Access comprehensive financial analyses and make smarter investments - get the Manual of Investments on Amazon!

AGCO Q1 Net Sales Surge 14.3%

AGCO’s first-quarter net sales rose to $2.34 billion from $2.05 billion a year earlier, up 14.3%, with 4.7% of the gain coming from higher volume and pricing after stripping out currency effects. Reported earnings increased to $0.76 per share from $0.14, while adjusted earnings climbed to $0.94 per share from $0.41.

Europe/Middle East was the company’s biggest growth engine, with sales of $1.60 billion, up 20.3% from $1.33 billion. North America sales rose 10.0% to $406.4 million from $369.5 million. Asia/Pacific/Africa sales jumped 31.2% to $124.0 million from $94.5 million. Latin America moved the other way, with sales falling 17.3% to $211.7 million from $256.0 million.

Excluding currency, Europe/Middle East sales were up 9.0%, North America up 9.0%, Asia/Pacific/Africa up 20.9%, and Latin America down 30.3%.

On profitability by region, Europe/Middle East posted a 16.2% operating margin, North America was at negative 12.5%, Latin America at negative 19.3%, and Asia/Pacific/Africa at 3.2%. AGCO said North America operating income fell by $26.8 million year over year, Latin America by $47.4 million, Europe/Middle East rose by $104.6 million, and Asia/Pacific/Africa increased by $6.7 million.

The company lifted its full-year adjusted earnings target to about $6.00 per share and kept its 2026 sales outlook at $10.5 billion to $10.7 billion. It also raised the regular quarterly dividend to $0.30 from $0.29 and plans to begin $350 million in share repurchases in the second quarter.

AGCO also said it agreed to sell its 49% stakes in its U.S. and Canada finance joint ventures for about $190 million, with the proceeds earmarked for buybacks. As a result of these announcements, the company's shares have moved -0.35% on the market, and are now trading at a price of $120.86. For the full picture, make sure to review 's 8-K report.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS